HØRSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (CSE:LCP) has decided to increase its share capital by nom. 150,813 shares as a consequence of the exercise of warrants. The increase is executed without any pre-emption rights for the existing shareholders of the company or others.
